These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15201863)

  • 1. Genetic control of autoantibody expression in autoimmune myasthenia gravis: role of the self-antigen and of HLA-linked loci.
    Giraud M; Beaurain G; Eymard B; Tranchant C; Gajdos P; Garchon HJ
    Genes Immun; 2004 Aug; 5(5):398-404. PubMed ID: 15201863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the AChRalpha-subunit gene (CHRNA), DQA1*0101, and the DR3 haplotype in myasthenia gravis. Evidence for a three-gene disease model in a subgroup of patients.
    Djabiri F; Caillat-Zucman S; Gajdos P; Jaïs JP; Gomez L; Khalil I; Charron D; Bach JF; Garchon HJ
    J Autoimmun; 1997 Aug; 10(4):407-13. PubMed ID: 9237805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia gravis, a model of organ-specific autoimmune disease.
    Berrih-Aknin S
    J Autoimmun; 1995 Apr; 8(2):139-43. PubMed ID: 7612144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.
    Nakata R; Motomura M; Masuda T; Shiraishi H; Tokuda M; Fukuda T; Ando T; Yoshimura T; Tsujihata M; Kawakami A
    Eur J Neurol; 2013 Sep; 20(9):1272-6. PubMed ID: 23679930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia.
    Vandiedonck C; Beaurain G; Giraud M; Hue-Beauvais C; Eymard B; Tranchant C; Gajdos P; Dausset J; Garchon HJ
    Proc Natl Acad Sci U S A; 2004 Oct; 101(43):15464-9. PubMed ID: 15489265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy.
    Tola MR; Caniatti LM; Casetta I; Granieri E; Conighi C; Quatrale R; Monetti VC; Paolino E; Govoni V; Pascarella R
    Acta Neurol Scand; 1994 Nov; 90(5):318-23. PubMed ID: 7887131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study.
    Chia R; Saez-Atienzar S; Murphy N; Chiò A; Blauwendraat C; ; Roda RH; Tienari PJ; Kaminski HJ; Ricciardi R; Guida M; De Rosa A; Petrucci L; Evoli A; Provenzano C; Drachman DB; Traynor BJ
    Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35074870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of autoimmune myasthenia gravis, a model for antibody-mediated autoimmunity in man.
    Garchon HJ
    J Autoimmun; 2003 Sep; 21(2):105-10. PubMed ID: 12935778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathymic expression of neuromuscular acetylcholine receptors and the immunpathogenesis of myasthenia gravis.
    Levinson AI; Zheng Y; Gaulton G; Song D; Moore J; Pletcher CH
    Immunol Res; 2003; 27(2-3):399-408. PubMed ID: 12857984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping myasthenia gravis-associated T cell epitopes on human acetylcholine receptors in HLA transgenic mice.
    Yang H; Goluszko E; David C; Okita DK; Conti-Fine B; Chan TS; Poussin MA; Christadoss P
    J Clin Invest; 2002 Apr; 109(8):1111-20. PubMed ID: 11956249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.
    Hohlfeld R; Conti-Tronconi B; Kalies I; Bertrams J; Toyka KV
    J Immunol; 1985 Oct; 135(4):2393-9. PubMed ID: 2411794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular myasthenia gravis induced by human acetylcholine receptor ϵ subunit immunization in HLA DR3 transgenic mice.
    Wu X; Tuzun E; Saini SS; Wang J; Li J; Aguilera-Aguirre L; Huda R; Christadoss P
    Immunol Lett; 2015 Dec; 168(2):306-12. PubMed ID: 26493475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity in myasthenia gravis: HLA phenotypes and autoantibody responses in ocular and generalized types.
    Kida K; Hayashi M; Yamada I; Matsuda H; Yoshinaga J; Takami S; Yashiki S; Sonoda S
    Ann Neurol; 1987 Mar; 21(3):274-8. PubMed ID: 3606034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
    Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA
    J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients.
    Oshima M; Deitiker PR; Smith RG; Mosier D; Atassi MZ
    Autoimmunity; 2012 Mar; 45(2):153-60. PubMed ID: 21985279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DQA1*03:02/DQB1*03:03:02 is strongly associated with susceptibility to childhood-onset ocular myasthenia gravis in Southern Han Chinese.
    Zhu WH; Lu JH; Lin J; Xi JY; Lu J; Luo SS; Qiao K; Xiao BG; Lu CZ; Zhao CB
    J Neuroimmunol; 2012 Jun; 247(1-2):81-5. PubMed ID: 22503410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms.
    Hong Y; Skeie GO; Zisimopoulou P; Karagiorgou K; Tzartos SJ; Gao X; Yue YX; Romi F; Zhang X; Li HF; Gilhus NE
    J Neurol; 2017 May; 264(5):955-962. PubMed ID: 28364296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis with thymic hyperplasia is associated with polymorphisms in the tumor necrosis factor region.
    Hjelmström P; Peacock CS; Giscombe R; Pirskanen R; Lefvert AK; Blackwell JM; Sanjeevi CB
    Ann N Y Acad Sci; 1998 May; 841():368-70. PubMed ID: 9668261
    [No Abstract]   [Full Text] [Related]  

  • 19. Combinations of HLA-DPB1 and HLA-DQB1 alleles determine susceptibility to early-onset myasthenia gravis in Japan.
    Horiki T; Inoko H; Moriuchi J; Ichikawa Y; Arimori S
    Autoimmunity; 1994; 19(1):49-54. PubMed ID: 7749041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor.
    Vrolix K; Fraussen J; Losen M; Stevens J; Lazaridis K; Molenaar PC; Somers V; Bracho MA; Le Panse R; Stinissen P; Berrih-Aknin S; Maessen JG; Van Garsse L; Buurman WA; Tzartos SJ; De Baets MH; Martinez-Martinez P
    J Autoimmun; 2014 Aug; 52():101-12. PubMed ID: 24439114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.